Page last updated: 2024-10-26

doxazosin and Brain Infarction

doxazosin has been researched along with Brain Infarction in 1 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Research Excerpts

ExcerptRelevanceReference
"We conducted ambulatory BP monitoring three times (twice at baseline and after nighttime dosing of the alpha1-blocker doxazosin) in 98 elderly hypertensive patients in whom the presence of silent cerebral infarcts (SCI) was assessed by brain magnetic resonance imaging."5.11Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. ( Eguchi, K; Hoshide, S; Hoshide, Y; Ishikawa, J; Kario, K; Morinari, M; Pickering, TG; Shimada, K, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kario, K1
Pickering, TG1
Hoshide, S1
Eguchi, K1
Ishikawa, J1
Morinari, M1
Hoshide, Y1
Shimada, K1

Trials

1 trial available for doxazosin and Brain Infarction

ArticleYear
Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system.
    American journal of hypertension, 2004, Volume: 17, Issue:8

    Topics: Adrenergic alpha-Antagonists; Aged; Aging; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Br

2004